Apollo Hospitals Enterprise (BOM:508869) EBIT: ₹31,105 Mil (TTM As of Mar. 2026)


BOM:508869 Apollo Hospitals Enterprise Ltd BOM:508869
92 GF Score
Price ₹8,697.55
GF Value ₹8,723.27
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Apollo Hospitals Enterprise EBIT?

Apollo Hospitals Enterprise BOM:508869 +0.94% 92 EBIT is ₹31,105 Mil as of Mar. 2026. GuruFocus rates BOM:508869 with a GF Score™ of 92/100 and a GF Value™ of ₹8,723.27 (Fairly Valued). The stock has 4 warning signs investors should review.

Apollo Hospitals Enterprise's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ₹8,406 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹31,105 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Apollo Hospitals Enterprise's annualized ROC % for the quarter that ended in Mar. 2026 was 12.31%. Apollo Hospitals Enterprise's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 25.26%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Apollo Hospitals Enterprise's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 2.36%.


Apollo Hospitals Enterprise  (BOM:508869) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Apollo Hospitals Enterprise's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=31464 * ( 1 - 23.59% )/( (0 + 195240)/ 1 )
=24041.6424/195240
=12.31 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Apollo Hospitals Enterprise's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=33624/( ( (0 + max(0, 0)) + (120301 + max(12805, 0)) )/ 1 )
=33624/( ( 0 + 133106 )/ 1 )
=33624/133106
=25.26 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(34849 + 5424 + 3420) - (22544 + 0 + 8344)
=12805

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Apollo Hospitals Enterprise's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=31105/1316805.377
=2.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Apollo Hospitals Enterprise EBIT Related Terms


Apollo Hospitals Enterprise EBIT Historical Data

* Premium members only.

The historical data trend for Apollo Hospitals Enterprise's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apollo Hospitals Enterprise EBIT Chart

Apollo Hospitals Enterprise Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19,085.00 14,574.00 17,906.00 24,976.00 31,105.00

Apollo Hospitals Enterprise Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,303.00 6,910.00 7,843.00 7,946.00 8,406.00

BOM:508869 vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Apollo Hospitals Enterprise's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apollo Hospitals Enterprise EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Apollo Hospitals Enterprise's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Apollo Hospitals Enterprise's EV-to-EBIT falls into.


BOM:508869
92GF Score
Apollo Hospitals Enterprise Ltd BOM:508869
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apollo Hospitals Enterprise EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹31,105 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹31,105 Mil mean?
Apollo Hospitals Enterprise (BOM:508869) has a EBIT of ₹31,105 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Apollo Hospitals Enterprise.
Is Apollo Hospitals Enterprise's EBIT too high?
Apollo Hospitals Enterprise's current EBIT is ₹31,105 Mil. Overall, Apollo Hospitals Enterprise has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Apollo Hospitals Enterprise's EBIT compare to HCA and THC?
Apollo Hospitals Enterprise's EBIT of ₹31,105 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Apollo Hospitals Enterprise. Apollo Hospitals Enterprise's current EBIT is ₹31,105 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apollo Hospitals Enterprise stock overvalued right now?
Based on GuruFocus' analysis, Apollo Hospitals Enterprise (BOM:508869) is currently considered Fairly Valued. The stock's GF Value™ is ₹8,723.27, compared to a current price of ₹8,697.55 — trading 0.3% below its estimated fair value. The current EBIT is ₹31,105 Mil. Apollo Hospitals Enterprise's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Apollo Hospitals Enterprise (BOM:508869), the current EBIT is ₹31,105 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Apollo Hospitals Enterprise (BOM:508869) Overvalued in 2026?

Based on GuruFocus' analysis, Apollo Hospitals Enterprise stock appears to be undervalued. The current stock price of ₹8,697.55 is trading 0.3% below its estimated GF Value™ of ₹8,723.27. GuruFocus considers Apollo Hospitals Enterprise to be Fairly Valued.

Key valuation signals for BOM:508869:

  • EBIT: ₹31,105 Mil
  • GF Value™: ₹8,723.27 vs. price of ₹8,697.55 (0.3% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the BOM:508869 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Apollo Hospitals Enterprise Business Description

Other Exchanges APOLLOHOSP:India
Address No. 8-17, Shafee Mohammed Road, Sunny Side Building, East Block, 3rd Floor, Chennai, TN, IND, 600006
Apollo Hospitals Enterprise Ltd operates a network of private hospitals in India through primary, secondary, and tertiary care facilities. The firm's tertiary care hospitals provide complex care in a variety of specialties that include cardiology, oncology, neuroscience, orthopedics, radiology, and gastroenterology. Apollo Hospitals also operates primary care and diagnostics clinics as well as telemedicine units and offers consulting, health insurance, education and training, and research services. Its reportable operating segments are; Healthcare Services (represents hospitals and hospitals services); Retail Health and Diagnostics (includes clinics and diagnostics); Digital Health and Pharmacy Distribution; and Others. Maximum revenue is generated from its Healthcare Services segment.
92GF Score

Get the complete analysis for BOM:508869

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹8,697.55
Price
₹8,723.27
GF Value